Drinkable molecule interferes with a crucial first step of Alzheimer’s
Yale University - 02-Jan-2019Improvements in laboratory technology enable mass screening of molecules like these
Erik Gunther
Associate Research Scientist in Neurology at Yale University.
Erik graduated with honors from the University of California at Santa Cruz (1993), received a PhD in Cellular and Molecular Biology from the University of Washington (2001) and was Senior Scientist in the Central Nervous System Department of CuraGen, Inc. before entering the Center for Neurodegeneration and Neurorepair under the Department of Neurology at Yale (2005).
Visit website: https://medicine.yale.edu/neurology/profile/erik_gunther/
See also
Details last updated 09-Jan-2020
Erik Gunther News
